» Articles » PMID: 31415710

Perceived Discrimination, Trust in Physicians, and Prolonged Symptom Duration Before Ovarian Cancer Diagnosis in the African American Cancer Epidemiology Study

Abstract

Background: Discrimination and trust are known barriers to accessing health care. Despite well-documented racial disparities in the ovarian cancer care continuum, the role of these barriers has not been examined. This study evaluated the association of everyday discrimination and trust in physicians with a prolonged interval between symptom onset and ovarian cancer diagnosis (hereafter referred to as prolonged symptom duration).

Methods: Subjects included cases enrolled in the African American Cancer Epidemiology Study, a multisite case-control study of epithelial ovarian cancer among black women. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for associations of everyday discrimination and trust in physicians with a prolonged symptom duration (1 or more symptoms lasting longer than the median symptom-specific duration), and it controlled for access-to-care covariates and potential confounders.

Results: Among the 486 cases in this analysis, 302 women had prolonged symptom duration. In the fully adjusted model, a 1-unit increase in the frequency of everyday discrimination increased the odds of prolonged symptom duration 74% (OR, 1.74; 95% CI, 1.22-2.49), but trust in physicians was not associated with prolonged symptom duration (OR, 0.86; 95% CI, 0.66-1.11).

Conclusions: Perceived everyday discrimination was associated with prolonged symptom duration, whereas more commonly evaluated determinants of access to care and trust in physicians were not. These results suggest that more research on the effects of interpersonal barriers affecting ovarian cancer care is warranted.

Citing Articles

Race and ethnicity and self-reported racial/ethnic discrimination in breast cancer patient interactions with providers in the Pathways Study.

Bitsie K, Pearson T, Kwan M, Yaghjyan L, Scarton L, Shariff-Marco S Breast Cancer Res Treat. 2024; 209(2):355-366.

PMID: 39367950 PMC: 11785627. DOI: 10.1007/s10549-024-07499-0.


Diagnostic experiences of Black and White patients with uterine cancer: A qualitative study.

Britton M, Izampuye E, Clark M, Ornstein R, Nunez-Smith M, Wright J Gynecol Oncol. 2024; 191:67-73.

PMID: 39362045 PMC: 11637892. DOI: 10.1016/j.ygyno.2024.09.010.


Neighborhood-level deprivation and survival in lung cancer.

Kennedy K, Jusue-Torres I, Buller I, Rossi E, Mallisetty A, Rodgers K BMC Cancer. 2024; 24(1):959.

PMID: 39107707 PMC: 11301857. DOI: 10.1186/s12885-024-12720-w.


Perceived discrimination and quality of life for African American and Caucasian American cancer patients: a coping mediation analysis of subtle and overt microaggressions.

Merluzzi T, Salamanca-Balen N, Philip E Ethn Health. 2024; 29(4-5):484-504.

PMID: 38698588 PMC: 11250902. DOI: 10.1080/13557858.2024.2347569.


African American and Hispanic Cancer Survivors' and Caregivers' Experiences in Nebraska.

Ratnapradipa K, Napit K, King K, Ramos A, Luma L, Dinkel D J Immigr Minor Health. 2024; 26(3):554-568.

PMID: 38180583 DOI: 10.1007/s10903-023-01570-6.


References
1.
Vine M, Calingaert B, Berchuck A, Schildkraut J . Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003; 90(1):75-82. DOI: 10.1016/s0090-8258(03)00175-6. View

2.
Park H, Ruterbusch J, Cote M . Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes. Cancer Epidemiol Biomarkers Prev. 2017; 26(10):1511-1518. PMC: 6859937. DOI: 10.1158/1055-9965.EPI-17-0290. View

3.
Casagrande S, Gary T, LaVeist T, Gaskin D, Cooper L . Perceived discrimination and adherence to medical care in a racially integrated community. J Gen Intern Med. 2007; 22(3):389-95. PMC: 1824749. DOI: 10.1007/s11606-006-0057-4. View

4.
Seibaek L, Petersen L, Blaakaer J, Hounsgaard L . Symptom interpretation and health care seeking in ovarian cancer. BMC Womens Health. 2011; 11:31. PMC: 3135550. DOI: 10.1186/1472-6874-11-31. View

5.
Evans J, Ziebland S, McPherson A . Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of 'total patient delay'. Fam Pract. 2006; 24(1):48-55. DOI: 10.1093/fampra/cml063. View